PETX - Aratana Therapeutics Inc.
Previous close
4.92
4.920 100.000%
Share volume: 0
Last Updated: Wed 17 Jul 2019 10:00:00 PM CEST
Pharmaceuticals: Generic:
0.65%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
11%
Profitability
0%
Dept financing
8%
Liquidity
75%
Performance
8%
Sector
Health Technology
Industry
Pharmaceuticals: Generic
Long-term ratios 2015 - 2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.54%
Return on assets
-5.69%
Return on sales
-3529.01%
Return on invested capital
-43.38%
Total debt ratio
28.72%
Debt ratio change over timeo
-1.64%
Current Ratio
4.32%
Quick Ratio
3.69%
Cash Position Ratio
3.28%
Short-term ratios 2018 - 2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-3.57%
Return on assets
-2.91%
Return on sales
-81.26%
Return on invested capital
-4.98%
Total debt ratio
15.7%
Debt ratio change over timeo
-1.47%
Current Ratio
5.83%
Quick Ratio
4.72%
Cash Position Ratio
4.03%
Last quarter ratios 2019
The data are presented for the financials results of the last quarter.
Return on equity
-7.05%
Return on assets
-6.65%
Return on sales
-94.59%
Return on invested capital
-15.9%
Total debt ratio
8.11%
Debt ratio change over time
-1.4%
Current Ratio
6.66%
Quick Ratio
5.32%
Cash Position Ratio
4.52%
Performance ratios (change over 4 years) 2015 - 2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-80.09%
Return on assets
-90.84%
Return on sales
1649.27%
Return on invested capital
-8.22%
Total debt ratio
-163.74%
Debt ratio change over time
-1.64%
Current Ratio
-7.7%
Quick Ratio
-6.73%
Cash Position Ratio
-5.88%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PETX | AGN | MYL | ABEOW |
|---|---|---|---|---|
| Return on equity | -10.54% | -0.11% | 0.98% | 0% |
| Return on assets | -5.69% | 0.02% | 0.94% | 0% |
| Return on sales | -3529.01% | 0.03% | 10.97% | 0% |
| Return on invested capital | -43.38% | 0.11% | 0.53% | 0% |
| Profitability | 0% | 5% | 100% | 0% |
| Total debt ratio | 28.72% | 38.39% | 64.23% | 0% |
| Debt ratio change over time | -1.64% | -130.64% | 129.05% | 0% |
| Dept financing | 11% | 15% | 50% | 0% |
| Current Ratio | 5.83% | 0.94% | 1.36% | 0% |
| Quick Ratio | 4.72% | 0.8% | 0.8% | 0% |
| Cash Position Ratio | 4.03% | 0.18% | 0.08% | 0% |
| Liquididy | 75% | 18% | 14% | 0% |
| Short-term ratios | PETX | AGN | MYL | ABEOW |
|---|---|---|---|---|
| Return on equity | -3.57% | -2.81% | 0.5% | 0% |
| Return on assets | -2.91% | 0.14% | 0.81% | 0% |
| Return on sales | -81.26% | 3.84% | 9.21% | 0% |
| Return on invested capital | -4.98% | -2.06% | 0.28% | 0% |
| Profitability | 0% | 15% | 100% | 0% |
| Total debt ratio | 15.7% | 35.41% | 63.2% | 0% |
| Debt ratio change over time | -1.47% | -270.92% | 219.31% | 0% |
| Dept financing | 6% | 14% | 50% | 0% |
| Current Ratio | 5.83% | 0.94% | 1.36% | 0% |
| Quick Ratio | 4.72% | 0.8% | 0.8% | 0% |
| Cash Position Ratio | 4.03% | 0.18% | 0.08% | 0% |
| Liquididy | 75% | 9% | 11% | 0% |